Federal Register / Vol. 76, No. 65 / Tuesday, April 5, 2011 / Notices 18769 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Environmental 

Health Sciences; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

Interagency Breast Cancer and 

Environmental Research Coordinating 

Committee. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

inform the Contact Person listed below 

at least 10 days in advance of the 

meeting. 

Name of Committee: Interagency Breast 

Cancer and Environmental Research 

Coordinating Committee (IBCERC). 

Date: May 12–13, 2011. 

Time: 8:30 a.m. to 5:30 p.m. 

Agenda: The purpose of the meeting is to 

continue the work of the Committee, which 

is to share and coordinate information on 

existing research activities, and to make 

recommendations to the National Institutes 

of Health and other Federal agencies 

regarding how to improve existing research 

programs related to breast cancer and the 

environment. In advance of the meeting, the 

agenda will be posted on the Web at 

http://www.niehs.nih.gov/about/orgstructure/ 

boards/ibcercc/. 

Place: National Institute of Environmental 

Health Sciences, Building 101, Rodbell 

Auditorium, 111 T.W. Alexander Drive, 

Research Triangle Park, NC 27709. 

Contact Person: Gwen W. Collman, PhD, 

Director, Division of Extramural Research 

and Training, National Institute of 

Environmental Health Sciences, 615 Davis 

Dr., KEY615/3112, Research Triangle Park, 

NC 27709. (919) 541–4980. 

collman@niehs.nih.gov. 

Any member of the public interested in 

presenting oral comments to the committee 

should submit their remarks in writing at 

least 10 days in advance of the meeting. 

Comments in document format (i.e. WORD, 

Rich Text, PDF) may be submitted via e-mail 

to ibcercc@niehs.nih.gov or mailed to the 

Contact Person listed on this notice. You do 

not need to attend the meeting in order to 

submit comments. 

Interested individuals and representatives 

of organizations may submit a letter of intent, 

a brief description of the organization 

represented, and a short description of the 

oral comments you wish to present. Only one 

representative per organization may be 

allowed to present oral comments and if 

accepted by the committee, presentations 

may be limited to five minutes. Both printed 

and electronic copies are requested for the 

record. The statement should include the 

name, address, telephone number and, when 

applicable, the business or professional 

affiliation of the interested person. Oral 

comments will begin at approximately 4 p.m. 

on Friday, May 13, 2011. Anyone who 

wishes to attend the meeting and/or submit 

comments to the committee is asked to RSVP 

via the following e-mail: 

ibcercc@niehs.nih.gov. All comments are 

delivered to the Contact Person listed on this 

notice. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.115, Biometry and Risk 

Estimation Health Risks from Environmental 

Exposures; 93.142, NIEHS Hazardous Waste 

Worker Health and Safety Training; 93.143, 

NIEHS Superfund Hazardous Substances— 

Basic Research and Education; 93.894, 

Resources and Manpower Development in 

the Environmental Health Sciences; 93.113, 

Biological Response to Environmental Health 

Hazards; 93.114, Applied Toxicological 

Research and Testing, National Institutes of 

Health, HHS) 

Dated: March 28, 2011. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2011–8048 Filed 4–4–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Prospective Grant of Exclusive 

License: Device and System for Two 

Dimensional Analysis of Biomolecules 

From Tissue and Other Samples 

AGENCY: National Institutes of Health, 

Public Health Service, HHS. 

ACTION: Notice. 

SUMMARY: This is notice, in accordance 

with 35 U.S.C. 209(c)(1) and 37 CFR 

part 404.7(a)(1)(i), that the National 

Institutes of Health, Department of 

Health and Human Services, is 

contemplating the grant of an exclusive 

patent license to practice the inventions 

embodied in PCT Patent Application 

No. PCT/US03/37208 [HHS Ref. No. E– 

339–2002/0–PCT–02], filed November 

20, 2003, which published as WO 2004/ 

048928 on June 10, 2004, now expired, 

entitled ‘‘Method And Apparatus for 

Performing Multiple Simultaneous 

Manipulations of Biomolecules In a 

Two-Dimensional Array;’’ U.S. Patent 

Application No. 10/535,521 [HHS Ref. 

No. E–339–2002/0–US–03], filed May 

18, 2005, now abandoned, which 

published as US–2006–0147926 A1 on 

July 6, 2006 entitled ‘‘Method And 

Apparatus for Performing Multiple 

Simultaneous Manipulations of 

Biomolecules In a Two-Dimensional 

Array;’’ U.S. Patent Application No. 12/ 

587,976 [HHS Ref. No. E–339–2002/0– 

US–04], filed October 14, 2009, which 

published as US–2010–010506 on April 

29, 2010 entitled ‘‘Device for External 

Movement Manipulation of Nucleic 

Acids and/or Proteins;’’ U.S. Provisional 

Patent Application No. 61/206,458 

[HHS Ref. No. E–130–2006/0–US–01] 

filed January 30, 2009, entitled, 

‘‘Amplification Platform and Methods of 

Use Thereof, now expired, and PCT 

Patent Application No. PCT/US10/ 

022586 [HHS Ref. No. E–130–2006/0– 

PCT–02] filed January 29, 2010 and 

which published as WO 2010/088517 

on August 5, 2010, entitled, ‘‘Methods 

and Systems for Purifying, Transferring 

and/or Manipulating Nucleic Acids;’’ 

and all continuing applications and 

foreign counterparts to 2–D Bio, LLC, 

having a place of business in 

Gaithersburg, Maryland. The patent 

rights in these inventions have been 

assigned to the United States of 

America. However, the patent rights for 

HHS Ref. No. E–130–2006/0–US–01 and 

HHS Ref. No. E–130–2006/0–PCT–02 

are co-owned and co-assigned to the 

University of Maryland. The United 

States of America has obtained an 

exclusive license to the University of 

Maryland’s rights in the invention. 

The prospective exclusive license 

territory may be ‘‘worldwide’’, and the 

field of use may be limited to 

‘‘development of devices for sale and 

services for high throughput parallel 

analysis and two dimensional analyses 

of molecules for all uses.’’ 

DATES: Only written comments and/or 

applications for a license which are 

received by the NIH Office of 

Technology Transfer on or before May 5, 

2011 will be considered. 

ADDRESSES: Requests for copies of the 

patent application, inquiries, comments, 

and other materials relating to the 

contemplated exclusive license should 

be directed to: Kevin W. Chang, PhD, 

Senior Licensing and Patenting 

Manager, Office of Technology Transfer, 

National Institutes of Health, 6011 

Executive Boulevard, Suite 325, 

Rockville, MD 20852–3804; Telephone: 

(301) 435–5018; Facsimile: (301) 402– 

0220; E-mail: changke@mail.nih.gov. 

SUPPLEMENTARY INFORMATION: The 

subject technologies are methods, 

systems, and devices for purifying, 

transferring, or manipulating 

biomolecules, including nucleic acids 

from a sample, or performing a 

combination thereof, that substantially 

preserve two-dimensional (2D) spatial 

information on the original locations of 

the biomolecules within the sample. 

The prospective exclusive license will 

be royalty bearing and will comply with 

the terms and conditions of 35 U.S.C. 


srobinson on DSKHWCL6B1PROD with NOTICES